Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

BACKGROUND: The presence of an oligodendroglial component within a glioblastoma multiforme (GBM) is considered a prognostically favorable factor, but the clinical outcome of patients with glioblastoma multiforme with oligodendroglial component (GBMO) after combined post-operative radiotherapy and ch...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vordermark, Dirk, Ruprecht, Klemens, Rieckmann, Peter, Roggendorf, Wolfgang, Vince, Giles H, Warmuth-Metz, Monika, Kölbl, Oliver, Flentje, Michael
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2006
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1621074/
https://ncbi.nlm.nih.gov/pubmed/17049083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-247
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars